Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1996 Jun;118(3):755–761. doi: 10.1111/j.1476-5381.1996.tb15464.x

Presynaptic modulation by L-glutamate and GABA of sympathetic co-transmission in rat isolated vas deferens.

Y W Kwan 1, M P Ngan 1, K Y Tsang 1, H M Lee 1, L A Chu 1
PMCID: PMC1909721  PMID: 8762104

Abstract

1. The modulatory effects of L-glutamate and its structural analogues, and of gamma-aminobutyric acid (GABA), on sympathetic co-transmission were studied in the rat isolated vas deferens exposed to electrical field stimulation (EFS). 2. Application of exogenous L-glutamate caused a concentration-dependent (1 microM-3 mM) inhibition of the rapid twitch component of the biphasic EFS contraction. However, L-glutamate (1 microM-3 mM) had a minimal effect on the phasic contraction induced by exogenous adenosine 5'-triphosphate (ATP, 150 microM) and noradrenaline (50 microM). Unlike L-glutamate, D-glutamate had no effect on the EFS contraction. 3. The L-glutamate-induced inhibition of the EFS contractions was significantly attenuated by the glutamate decarboxylase (GAD) inhibitor 3-mercapto-propionic acid (150 microM) and was abolished in the presence of the GABA transaminase (GABA-T) inhibitor, 2-aminoethyl hydrogen sulphate (500 microM). 4. The L-glutamate-induced inhibition of the electrically evoked contraction was not affected by the adenosine A1-receptor antagonist, 8-cyclopentyl-1,3-dipropylxanthine (DPCPX)(30 nM), reactive blue 2 (30 microM) or the GABAA receptor antagonist bicuculline (50 microM). However, the GABAB receptor antagonist 2-hydroxysaclofen (50 microM) significantly inhibited the L-glutamate effect. 5. Similar to L-glutamate, GABA also caused a concentration-dependent (0.1-100 microM) inhibition of the EFS contractions. This GABA-induced inhibition was not affected by either the GABAA receptor antagonist bicuculline (50 microM) or reactive blue 2 (30 microM). However, a significant attenuation of the GABA-mediated effect was recorded with the GABAB receptor antagonist 2-hydroxysaclofen (50 microM). Contractions of the vas deferens induced by exogenous ATP and noradrenaline were not affected by GABA (0.1-100 microM). 6. The L-glutamate analogues, N-methyl-D-aspartate (NMDA) (1 microM-1 mM) and quisqualate (Quis 0.1 microM-0.3 mM) had no effect, whilst kainate (Kain, 1 microM-1 mM) caused an inhibition of the EFS-induced contractions. Effects of Kain could be abolished by the non-NMDA receptor antagonist 6-cyano-7-nitroquinoxaline-2,3-dioxine (CNQX, 10 microM). NMDA, Quis and Kain had no effect on the exogenous ATP- or noradrenaline-induced contractions. 7. It is concluded that the excitatory amino acid L-glutamate modulates the electrically evoked vas deferens contraction through conversion to the inhibitory amino acid GABA by a specific GABA transaminase. The GABA formed may then act on GABAB receptors and cause inhibition of the contraction through a presynaptic mechanism.

Full text

PDF
755

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anton P. G., Duncan M. E., McGrath J. C. An analysis of the anatomical basis for the mechanical response to motor nerve stimulation of the rat vas deferens. J Physiol. 1977 Dec;273(1):23–43. doi: 10.1113/jphysiol.1977.sp012079. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bell C. Autonomic nervous control of reproduction: circulatory and other factors. Pharmacol Rev. 1972 Dec;24(4):657–736. [PubMed] [Google Scholar]
  3. Brown D. A., Docherty J. R., French A. M., MacDonald A., McGrath J. C., Scott N. C. Separation of adrenergic and non-adrenergic contractions to field stimulation in the rat vas deferens. Br J Pharmacol. 1983 Jun;79(2):379–393. doi: 10.1111/j.1476-5381.1983.tb11010.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Curtis D. R., Duggan A. W., Felix D., Johnston G. A. GABA, bicuculline and central inhibition. Nature. 1970 Jun 27;226(5252):1222–1224. doi: 10.1038/2261222a0. [DOI] [PubMed] [Google Scholar]
  5. Daly J. W. Adenosine receptors: targets for future drugs. J Med Chem. 1982 Mar;25(3):197–207. doi: 10.1021/jm00345a001. [DOI] [PubMed] [Google Scholar]
  6. Erdö S. L., Rosdy B., Szporny L. Higher GABA concentrations in fallopian tube than in brain of the rat. J Neurochem. 1982 Apr;38(4):1174–1176. doi: 10.1111/j.1471-4159.1982.tb05368.x. [DOI] [PubMed] [Google Scholar]
  7. Evans R. H., Francis A. A., Jones A. W., Smith D. A., Watkins J. C. The effects of a series of omega-phosphonic alpha-carboxylic amino acids on electrically evoked and excitant amino acid-induced responses in isolated spinal cord preparations. Br J Pharmacol. 1982 Jan;75(1):65–75. doi: 10.1111/j.1476-5381.1982.tb08758.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Ferguson D. R., Marchant J. S. Inhibitory actions of GABA on rabbit urinary bladder muscle strips: mediation by potassium channels. Br J Pharmacol. 1995 May;115(1):81–83. doi: 10.1111/j.1476-5381.1995.tb16323.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Ferreira I. L., Duarte C. B., Santos P. F., Carvalho C. M., Carvalho A. P. Release of [3H]GABA evoked by glutamate receptor agonists in cultured chick retina cells: effect of Ca2+. Brain Res. 1994 Nov 21;664(1-2):252–256. doi: 10.1016/0006-8993(94)91981-x. [DOI] [PubMed] [Google Scholar]
  10. Fowler L. J., John R. A. Active-site-directed irreversible inhibition of rat brain 4-aminobutyrate aminotransferase by ethanolamine O-sulphate in vitro and in vivo. Biochem J. 1972 Nov;130(2):569–573. doi: 10.1042/bj1300569. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Furness J. B., Iwayama T. The arrangement and identification of axons innervating the vas deferens of the guinea-pig. J Anat. 1972 Nov;113(Pt 2):179–196. [PMC free article] [PubMed] [Google Scholar]
  12. Gonzales J. M., Loeb A. L., Reichard P. S., Irvine S. Ketamine inhibits glutamate-, N-methyl-D-aspartate-, and quisqualate-stimulated cGMP production in cultured cerebral neurons. Anesthesiology. 1995 Jan;82(1):205–213. doi: 10.1097/00000542-199501000-00025. [DOI] [PubMed] [Google Scholar]
  13. Gray J. A., Green A. R. GABAB-receptor mediated inhibition of potassium-evoked release of endogenous 5-hydroxytryptamine from mouse frontal cortex. Br J Pharmacol. 1987 Jul;91(3):517–522. doi: 10.1111/j.1476-5381.1987.tb11244.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Hofmann H. D., Möckel V. Release of gamma-amino[3H]butyric acid from cultured amacrine-like neurons mediated by different excitatory amino acid receptors. J Neurochem. 1991 Mar;56(3):923–932. doi: 10.1111/j.1471-4159.1991.tb02010.x. [DOI] [PubMed] [Google Scholar]
  15. Kerr D. I., Ong J., Johnston G. A., Abbenante J., Prager R. H. 2-Hydroxy-saclofen: an improved antagonist at central and peripheral GABAB receptors. Neurosci Lett. 1988 Sep 23;92(1):92–96. doi: 10.1016/0304-3940(88)90748-3. [DOI] [PubMed] [Google Scholar]
  16. Kurz A. K., Bültmann R., Driessen B., von Kügelgen I., Starke K. Release of ATP in rat vas deferens: origin and role of calcium. Naunyn Schmiedebergs Arch Pharmacol. 1994 Nov;350(5):491–498. doi: 10.1007/BF00173018. [DOI] [PubMed] [Google Scholar]
  17. Kusunoki M., Taniyama K., Tanaka C. Neuronal GABA release and GABA inhibition of ACh release in guinea pig urinary bladder. Am J Physiol. 1984 Apr;246(4 Pt 2):R502–R509. doi: 10.1152/ajpregu.1984.246.4.R502. [DOI] [PubMed] [Google Scholar]
  18. Lara H., Bastos-Ramos W. Glutamate and kainate effects on the noradrenergic neurons innervating the rat vas deferens. J Neurosci Res. 1988 Feb;19(2):239–244. doi: 10.1002/jnr.490190209. [DOI] [PubMed] [Google Scholar]
  19. Lohse M. J., Klotz K. N., Lindenborn-Fotinos J., Reddington M., Schwabe U., Olsson R. A. 8-Cyclopentyl-1,3-dipropylxanthine (DPCPX)--a selective high affinity antagonist radioligand for A1 adenosine receptors. Naunyn Schmiedebergs Arch Pharmacol. 1987 Aug;336(2):204–210. doi: 10.1007/BF00165806. [DOI] [PubMed] [Google Scholar]
  20. Maggi C. A., Santicioli P., Meli A. GABAA and GABAB receptors in detrusor strips from guinea-pig bladder dome. J Auton Pharmacol. 1985 Mar;5(1):55–64. doi: 10.1111/j.1474-8673.1985.tb00565.x. [DOI] [PubMed] [Google Scholar]
  21. Narahashi T. Chemicals as tools in the study of excitable membranes. Physiol Rev. 1974 Oct;54(4):813–889. doi: 10.1152/physrev.1974.54.4.813. [DOI] [PubMed] [Google Scholar]
  22. Pin J. P., Bockaert J. Two distinct mechanisms, differentially affected by excitatory amino acids, trigger GABA release from fetal mouse striatal neurons in primary culture. J Neurosci. 1989 Feb;9(2):648–656. doi: 10.1523/JNEUROSCI.09-02-00648.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Qume M., Whitton P. S., Fowler L. J. The effect of chronic treatment with the GABA transaminase inhibitors gamma-vinyl-GABA and ethanolamine-O-sulphate on the in vivo release of GABA from rat hippocampus. J Neurochem. 1995 May;64(5):2256–2261. doi: 10.1046/j.1471-4159.1995.64052256.x. [DOI] [PubMed] [Google Scholar]
  24. Rump L. C., von Kügelgen I. A study of ATP as a sympathetic cotransmitter in human saphenous vein. Br J Pharmacol. 1994 Jan;111(1):65–72. doi: 10.1111/j.1476-5381.1994.tb14024.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Sawaki K., Ouchi K., Sato T., Kawaguchi M. Existence of gamma-aminobutyric acid and its biosynthetic and metabolic enzymes in rat salivary glands. Jpn J Pharmacol. 1995 Apr;67(4):359–363. doi: 10.1254/jjp.67.359. [DOI] [PubMed] [Google Scholar]
  26. Schlicker E., Classen K., Göthert M. GABAB receptor-mediated inhibition of serotonin release in the rat brain. Naunyn Schmiedebergs Arch Pharmacol. 1984 Jun;326(2):99–105. doi: 10.1007/BF00517304. [DOI] [PubMed] [Google Scholar]
  27. Sneddon P., Burnstock G. Inhibition of excitatory junction potentials in guinea-pig vas deferens by alpha, beta-methylene-ATP: further evidence for ATP and noradrenaline as cotransmitters. Eur J Pharmacol. 1984 Apr 13;100(1):85–90. doi: 10.1016/0014-2999(84)90318-2. [DOI] [PubMed] [Google Scholar]
  28. Sneddon P., Machaly M. Regional variation in purinergic and adrenergic responses in isolated vas deferens of rat, rabbit and guinea-pig. J Auton Pharmacol. 1992 Dec;12(6):421–428. doi: 10.1111/j.1474-8673.1992.tb00390.x. [DOI] [PubMed] [Google Scholar]
  29. Taylor D. A., Wiese S., Faison E. P., Yarbrough G. G. Pharmacological characterization of purinergic receptors in the rat vas deferens. J Pharmacol Exp Ther. 1983 Jan;224(1):40–45. [PubMed] [Google Scholar]
  30. Todorov L. D., Bjur R. A., Westfall D. P. Temporal dissociation of the release of the sympathetic co-transmitters ATP and noradrenaline. Clin Exp Pharmacol Physiol. 1994 Nov;21(11):931–932. doi: 10.1111/j.1440-1681.1994.tb02469.x. [DOI] [PubMed] [Google Scholar]
  31. Watkins J. C., Krogsgaard-Larsen P., Honoré T. Structure-activity relationships in the development of excitatory amino acid receptor agonists and competitive antagonists. Trends Pharmacol Sci. 1990 Jan;11(1):25–33. doi: 10.1016/0165-6147(90)90038-a. [DOI] [PubMed] [Google Scholar]
  32. Westfall D. P., Stitzel R. E., Rowe J. N. The postjunctional effects and neural release of purine compounds in the guinea-pig vas deferens. Eur J Pharmacol. 1978 Jul 1;50(1):27–38. doi: 10.1016/0014-2999(78)90250-9. [DOI] [PubMed] [Google Scholar]
  33. White H. L. Glutamate as a precursor of GABA in rat brain and peripheral tissues. Mol Cell Biochem. 1981 Sep 25;39:253–259. doi: 10.1007/BF00232578. [DOI] [PubMed] [Google Scholar]
  34. von Kügelgen I., Kurz K., Starke K. P2-purinoceptor-mediated autoinhibition of sympathetic transmitter release in mouse and rat vas deferens. Naunyn Schmiedebergs Arch Pharmacol. 1994 Feb;349(2):125–132. doi: 10.1007/BF00169828. [DOI] [PubMed] [Google Scholar]
  35. von Kügelgen I., Späth L., Starke K. Adenosine but not an adenine nucleotide mediates tonic purinergic inhibition, as well as inhibition by glutamate, of noradrenaline release in rabbit brain cortex slices. Naunyn Schmiedebergs Arch Pharmacol. 1992 Dec;346(6):677–684. doi: 10.1007/BF00168742. [DOI] [PubMed] [Google Scholar]
  36. von Kügelgen I., Späth L., Starke K. Ionotropic glutamate receptor types leading to adenosine-mediated inhibition of electrically evoked [3H]-noradrenaline release in rabbit brain cortex slices. Br J Pharmacol. 1993 Dec;110(4):1544–1550. doi: 10.1111/j.1476-5381.1993.tb13999.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. von Kügelgen I., Späth L., Starke K. Stable adenine nucleotides inhibit [3H]-noradrenaline release in rabbit brain cortex slices by direct action at presynaptic adenosine A1-receptors. Naunyn Schmiedebergs Arch Pharmacol. 1992 Aug;346(2):187–196. doi: 10.1007/BF00165300. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES